Show simple item record

dc.contributor.authorVargesson, Neil
dc.contributor.authorStephens, Trent
dc.date.accessioned2023-03-02T00:04:19Z
dc.date.available2023-03-02T00:04:19Z
dc.date.issued2021-11-02
dc.identifier201628123
dc.identifier932ffb69-344c-408c-a0e5-da9630c86fd2
dc.identifier000713849900001
dc.identifier000713849900001
dc.identifier85118438702
dc.identifier.citationVargesson , N & Stephens , T 2021 , ' Thalidomide: History, withdrawal, renaissance and safety concerns ' , Expert Opinion on Drug Safety , vol. 20 , no. 12 , pp. 1455-1457 . https://doi.org/10.1080/14740338.2021.1991307en
dc.identifier.issn1474-0338
dc.identifier.otherJisc: 412dc451614c482dbd0625b0447f3426
dc.identifier.otherORCID: /0000-0001-8027-114X/work/145270748
dc.identifier.urihttp://aura-test.abdn.ac.uk/handle/2164/19455
dc.format.extent3
dc.format.extent82244
dc.language.isoeng
dc.relation.ispartofExpert Opinion on Drug Safetyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectdrug safetyen
dc.subjectmechanism of actionen
dc.subjectThalidomideen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleThalidomide: History, withdrawal, renaissance and safety concernsen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciences - Cell, Developmental and Cancer Biologyen
dc.description.statusPeer revieweden
dc.identifier.doihttps://doi.org/10.1080/14740338.2021.1991307
dc.date.embargoedUntil2022-11-02
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85118438702&partnerID=8YFLogxKen
dc.identifier.vol20en
dc.identifier.iss12en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record